Each Vial contains:
Quinupramine Sulphate. .2 gm
Each Vial contains:
Quinupramine Sulphate. .2 gm
Curative treatment of active Trypanosomiasis (e.g., Surra, Nagana).
Control of acute clinical signs like fever, anemia, and weakness.
Used as a preventative agent during periods of high tsetse fly exposure.
Effective against susceptible strains of Trypanosoma parasites.
Aids in the restoration of general health post-infection.
Quinupramine is a well-known trypanocidal drug. Its primary mechanism of action involves interfering with the essential metabolic processes of the Trypanosoma parasite, particularly by disrupting its energy production and nutrient uptake pathways. The drug rapidly accumulates in the parasite, causing structural damage and ultimately leading to parasite death. This direct action on the pathogen rapidly clears the infection from the bloodstream, thereby reversing the clinical signs of Trypanosomiasis such as fever and anemia.
Potent curative effect against circulating Trypanosoma parasites.
Rapid reduction of parasite load and immediate clinical distress.
Ease of administration after reconstitution into an injectable solution.
Supports animal recovery by halting parasite-induced anemia.
Crucial tool for managing trypanosomiasis outbreaks in endemic areas.
Cattle (Curative): Typically 1.5 - 2.5 mg/kg body weight
Deep Intramuscular (I.M.) injection.
Dissolve powder in sterile water as per package instructions to achieve recommended concentration.
Follow precise volume guidelines on the packaging for accurate dosing.
2 gm vial
Injection
Asia
America
Middle East
Africa
Anz
south America
EU
India